Wealthspire Advisors (Maryland)’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-283
Closed -$2K 2479
2019
Q1
$2K Buy
283
+51
+22% +$336 ﹤0.01% 2265
2018
Q4
$2K Sell
232
-14
-6% -$156 ﹤0.01% 2188
2018
Q3
$5K Buy
246
+2
+0.8% +$71 ﹤0.01% 1862
2018
Q2
$14K Buy
244
+28
+13% +$1.42K ﹤0.01% 1446
2018
Q1
$9K Sell
216
-13
-6% -$558 ﹤0.01% 1626
2017
Q4
$12K Hold
229
﹤0.01% 1533
2017
Q3
$10K Buy
229
+33
+17% +$1.5K ﹤0.01% 1590
2017
Q2
$10K Hold
196
﹤0.01% 1551
2017
Q1
$14K Sell
196
-5
-2% -$331 ﹤0.01% 1217
2016
Q4
$12K Sell
201
-56
-22% -$5.13K ﹤0.01% 1180
2016
Q3
$33K Buy
257
+46
+22% +$5.89K 0.01% 903
2016
Q2
$26K Buy
211
+38
+22% +$4.37K ﹤0.01% 917
2016
Q1
$14K Buy
173
+20
+13% +$1.65K ﹤0.01% 1111
2015
Q4
$15K Buy
+153
New +$16.4K ﹤0.01% 1083

Other funds holding ELGX

Wealthspire Advisors (Maryland)'s ELGX Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Endologix Inc (ELGX) in Q2 2019, closing a stake of 283 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in ELGX in Q4 2015 and held it in 14 quarters. The position peaked at $33K in Q3 2016. 75 funds tracked by Wall St. Rank hold ELGX as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Endologix Inc position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 283 Endologix Inc shares in Q2 2019, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in Endologix Inc in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Endologix Inc position peaked at $33K in Q3 2016.
  • 75 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.